These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

349 related articles for article (PubMed ID: 23188748)

  • 1. Pharmacogenomics discovery and implementation in genome-wide association studies era.
    Ni X; Zhang W; Huang RS
    Wiley Interdiscip Rev Syst Biol Med; 2013; 5(1):1-9. PubMed ID: 23188748
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Promise of personalized omics to precision medicine.
    Chen R; Snyder M
    Wiley Interdiscip Rev Syst Biol Med; 2013; 5(1):73-82. PubMed ID: 23184638
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacogenomics and individualized medicine: translating science into practice.
    Crews KR; Hicks JK; Pui CH; Relling MV; Evans WE
    Clin Pharmacol Ther; 2012 Oct; 92(4):467-75. PubMed ID: 22948889
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Towards structural systems pharmacology to study complex diseases and personalized medicine.
    Xie L; Ge X; Tan H; Xie L; Zhang Y; Hart T; Yang X; Bourne PE
    PLoS Comput Biol; 2014 May; 10(5):e1003554. PubMed ID: 24830652
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The success of pharmacogenomics in moving genetic association studies from bench to bedside: study design and implementation of precision medicine in the post-GWAS era.
    Ritchie MD
    Hum Genet; 2012 Oct; 131(10):1615-26. PubMed ID: 22923055
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The need to shift pharmacogenetic research from candidate gene to genome-wide association studies.
    Linskey DW; Linskey DC; McLeod HL; Luzum JA
    Pharmacogenomics; 2021 Nov; 22(17):1143-1150. PubMed ID: 34608812
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacogenomic Discovery Delineating the Genetic Basis of Drug Response.
    Zhang W; Zheng Y; Hou L
    Curr Genet Med Rep; 2013 Sep; 1(3):143-149. PubMed ID: 24015375
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chapter 7: Pharmacogenomics.
    Karczewski KJ; Daneshjou R; Altman RB
    PLoS Comput Biol; 2012; 8(12):e1002817. PubMed ID: 23300409
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lymphoblastoid cell lines in pharmacogenomic discovery and clinical translation.
    Wheeler HE; Dolan ME
    Pharmacogenomics; 2012 Jan; 13(1):55-70. PubMed ID: 22176622
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of the 1000 genomes project on the next wave of pharmacogenomic discovery.
    Zhang W; Dolan ME
    Pharmacogenomics; 2010 Feb; 11(2):249-56. PubMed ID: 20136363
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genome-wide association studies in pharmacogenomics: successes and lessons.
    Motsinger-Reif AA; Jorgenson E; Relling MV; Kroetz DL; Weinshilboum R; Cox NJ; Roden DM
    Pharmacogenet Genomics; 2013 Aug; 23(8):383-94. PubMed ID: 20639796
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Variant discovery using next-generation sequencing and its future role in pharmacogenetics.
    Russell LE; Schwarz UI
    Pharmacogenomics; 2020 May; 21(7):471-486. PubMed ID: 32338137
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The emerging era of pharmacogenomics: current successes, future potential, and challenges.
    Lee JW; Aminkeng F; Bhavsar AP; Shaw K; Carleton BC; Hayden MR; Ross CJ
    Clin Genet; 2014 Jul; 86(1):21-8. PubMed ID: 24684508
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Report on the 8th Annual Cold Spring Harbor/Wellcome Trust meeting on Pharmacogenomics and Personalized Medicine.
    Carr DF; Alfirevic A
    Pharmacogenomics; 2011 Mar; 12(3):315-7. PubMed ID: 21449671
    [No Abstract]   [Full Text] [Related]  

  • 15. Pharmacogenomics in clinical practice and drug development.
    Harper AR; Topol EJ
    Nat Biotechnol; 2012 Nov; 30(11):1117-24. PubMed ID: 23138311
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Progress towards the integration of pharmacogenomics in practice.
    Mooney SD
    Hum Genet; 2015 May; 134(5):459-65. PubMed ID: 25238897
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genome-wide association study: a useful tool to identify common genetic variants associated with drug toxicity and efficacy in cancer pharmacogenomics.
    Low SK; Takahashi A; Mushiroda T; Kubo M
    Clin Cancer Res; 2014 May; 20(10):2541-52. PubMed ID: 24831277
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacogenomics in the age of personalized medicine.
    Dickmann LJ; Ware JA
    Drug Discov Today Technol; 2016; 21-22():11-16. PubMed ID: 27978982
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacogenomics in the clinic.
    Relling MV; Evans WE
    Nature; 2015 Oct; 526(7573):343-50. PubMed ID: 26469045
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evidence and resources to implement pharmacogenetic knowledge for precision medicine.
    Caudle KE; Gammal RS; Whirl-Carrillo M; Hoffman JM; Relling MV; Klein TE
    Am J Health Syst Pharm; 2016 Dec; 73(23):1977-1985. PubMed ID: 27864205
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.